A selective PI 3-Kγ isoform inhibitor (IC50 = 0.24, 1.45, 0.07 and 1.70μM for α, β, γ and δ isoforms respectively). Blocks RANTES-induced neutrophil migration and displays anti-inflammatory activity in various in vivo rodent models.
Product Specification
Alternative Name: | NSC31098, 5-Benzo[1,3]dioxol-5-ylmethylene-thiazolidine-2,4-dione |
|
Formula: | C11H7NO4S |
|
MW: | 249.2 |
|
CAS: | 6318-41-8 |
|
Purity: | ≥98% (TLC) |
|
Appearance: | Yellow solid. |
|
Solubility: | Soluble in DMSO (25mg/mL). For in vivo administration this compound was suspended in 0.5% carboxymethylcellulose/0.25% Tween 20 as a vehicle. |
|
Shipping: | Ambient |
|
Long Term Storage: | Ambient |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment: C. Ferrandi, et al.; J. Pharmacol. Exp. Ther.
322, 923 (2007),
Abstract;